Loading market dashboard
Invesco International Dividend Achievers ETF
PIDFinancial ServicesNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda announced that TAK-881-3001, a pivotal Phase 2/3 clinical trial in Primary Immunodeficiency Disease (PID) patients, met its primary endpoint.
BCS Wealth Management increased its stake in Invesco International Dividend Achievers ETF (NASDAQ: PID) by 100.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 54,698 shares of the company's stock after purchasing an additional 27,349 shares during the period. BCS Wealth Management owned
